This message was sent to ##Email##
|
| October 12, 2016 |
| |  | | |
|
|
|
| |
Medical News Today
Human papillomavirus is currently the most commonly sexually transmitted infection, affecting around 79 million Americans and causing about 38,793 cancers each year. While there is a vaccine to protect against cancers caused by the virus, a new study finds that parents' willingness to vaccinate their child depends on the language used by their physician upon vaccine recommendation.
READ MORE
ASCT
It is with great sadness that we report the passing of ASCT founding member and Past-President Florence Woodworth Patten during the summer. She lived a remarkable life and will be greatly missed by friends, family, and colleagues alike. Her memorial is available at www.flintofts.com. We encourage you to visit the site, sign the online guest book and share a memory of Florence.
| Date |
Event |
Location |
More information |
Oct. 19, 2016
2 p.m. EST
|
Ergonomics in Microscopy |
Your PC |
 Thomas Hartigan, MSA, OT/L
Rutland Regional Medical Center
Program Director
More info |
Register
|
Jan. 18, 2017
2 p.m. EST
|
Simple & Potentially Life Saving, Exfoliative Anal Cytology |
Your PC |
 Charles D. Sturgis, MD
Associate Professor of Pathology
Cleveland Clinic Lerner College of Medicine of Case Western Reserve University
Cleveland Clinic Staff Cytopathologist
R.J. Tomsich Pathology & Lab Medicine Institute
More info |
Register
|
Available for 6 months after subscribing |
Quality Assessment Center (QAC) Cell Blocks Basics Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
Document Control for Cytopathology Workbench
|
Your PC |
Details |
Available for 6 months after subscribing |
Quality Assessment Center (QAC)
The LEAN Cytopathology Laboratory Workbench
|
Your PC |
Details |
Medscape
Extending the screening interval for cervical cancer among women aged 40 years who test negative for human papillomavirus (HPV) is safe and does not increase the risk for either cancer or precancerous neoplasia, say Dutch researchers.
On the basis of new data from the Netherlands, they suggest that the interval for cervical screening for such individuals (HPV-negative status and being older than 40 years) could be extended from 5 years to 10 years; all other women should continue to be screened every 5 years. The article was published online October 4 in the BMJ.
READ MORE
ScienceDaily
A study suggests that age is an important factor in the association between cancer and sugar-sweetened beverages and recommends that intervention programs to reduce consumption of added sugar be focused on lower socio-economic status, young males, as well as cervical cancer survivors.
READ MORE
HealthDay via Montana Standard
The way to increase the number of girls and boys who get the human papillomavirus vaccine may be as simple as giving it as part of a routine bundle of vaccines, a new study suggests.
The HPV vaccine, which guards against the virus that causes most cervical cancers, is only being used in just over half of teen girls in the United States, lagging far behind other recommended vaccinations in this age group.
But, by lumping HPV in with other required vaccinations, a Denver clinic was able to dramatically increase vaccination rates to nearly 90 percent in boys and girls, researchers report.
READ MORE
CBS News
The vaccine against human papillomavirus infection, which doctors believe causes most cases of cervical cancer, appears even more effective than believed, a new study finds.
"After eight years of vaccination, the reduction in the incidence of cervical neoplasia [abnormal growth of cells], including pre-cancers, have been reduced approximately 50 percent. This is greater than what was expected — that's pretty exciting," said lead researcher Cosette Wheeler. She is a professor of pathology and obstetrics and gynecology at the University of New Mexico, in Albuquerque.
READ MORE
Medscape
New recommendations that aim to help doctors communicate more efficiently with patients who are newly diagnosed with human papillomavirus (HPV)-related head and neck cancer have been issued by the European Head and Neck Cancer Society's Make Sense Campaign.
The recommendations were published in the Annals of Oncology. The risk factors for HPV-related head and neck cancer include a higher number of orogenital sexual partners, the authors comment.
READ MORE
Cancer Therapy Advisor
Human papillomavirus (HPV)-negative women have low long-term incidence of cervical cancer and cervical intraepithelial neoplasia (CIN) grade 3 or worse (CIN3+), which supports an extension of the cervical screening interval beyond five years for certain women, according to a study published in The BMJ. Maaike G. Dijkstra, M.D., from the VU University Medical Center in Amsterdam, and colleagues conducted a 14-year follow-up of 43,339 women aged 29 to 61 years with a negative HPV and/or negative cytology test. Participants were randomly assigned to HPV and cytology co-testing (intervention) or cytology-only testing (control).
READ MORE
Medical Xpress
When it comes to cancer-causing viruses like human papillomavirus, or HPV, researchers are continuing to find that infection with one strain may be better than another. In an analysis of survival data for patients with a particular type of head and neck cancer, researchers from the University of North Carolina Lineberger Comprehensive Cancer Center confirmed findings that a particular strain of HPV.
READ MORE
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
